instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | ESCITALOPRAM OXALATE, POLYMYXIN B | DrugsGivenReaction | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypomagnesaemia'. | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | ESCITALOPRAM OXALATE, POLYMYXIN B | DrugsGivenReaction | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Insomnia'. | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | ESCITALOPRAM OXALATE, POLYMYXIN B | DrugsGivenReaction | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic alkalosis'. | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | ESCITALOPRAM OXALATE, POLYMYXIN B | DrugsGivenReaction | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Musculoskeletal stiffness'. | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | ESCITALOPRAM OXALATE, POLYMYXIN B | DrugsGivenReaction | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraesthesia'. | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | ESCITALOPRAM OXALATE, POLYMYXIN B | DrugsGivenReaction | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudomonas test positive'. | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TEICOPLANIN | DrugsGivenReaction | CC BY | 33891671 | 20,946,416 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tremor'. | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | ESCITALOPRAM OXALATE, POLYMYXIN B | DrugsGivenReaction | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the dosage of drug 'ESCITALOPRAM OXALATE'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | UNKNOWN | DrugDosageText | CC BY | 33891671 | 20,701,808 | 2021-04-23 |
What was the dosage of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | UNKNOWN | DrugDosageText | CC BY | 33891671 | 20,701,808 | 2021-04-23 |
What was the dosage of drug 'TEICOPLANIN'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | UNKNOWN | DrugDosageText | CC BY | 33891671 | 20,701,808 | 2021-04-23 |
What was the outcome of reaction 'Acinetobacter test positive'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 20,946,416 | 2021-04-23 |
What was the outcome of reaction 'Acute kidney injury'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovered | ReactionOutcome | CC BY | 33891671 | 20,701,808 | 2021-04-23 |
What was the outcome of reaction 'Anxiety'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Drug ineffective'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 20,946,416 | 2021-04-23 |
What was the outcome of reaction 'Dysphagia'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Dyspnoea'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Hypocalcaemia'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovered | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Hypokalaemia'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovered | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Hypomagnesaemia'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovered | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Insomnia'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Metabolic alkalosis'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Musculoskeletal stiffness'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Paraesthesia'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
What was the outcome of reaction 'Pseudomonas test positive'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 20,946,416 | 2021-04-23 |
What was the outcome of reaction 'Tremor'? | Polymyxin Acute Kidney Injury: a case of severe tubulopathy.
Polymyxins are antibiotics developed in the 1950s. Polymyxin-induced neurotoxicity has been often described in medical literature. The same cannot be said of nephrotoxicity or tubulopathy in particular. This report describes the case of a patient prescribed p... | Recovering | ReactionOutcome | CC BY | 33891671 | 19,218,361 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothyroidism'. | A case of thyrotoxicosis-induced anemia in a patient with painless thyroiditis.
BACKGROUND
There have been several reports of secondary anemia associated with Graves' disease. There are no reports of secondary anemia resulting from thyrotoxicosis due to painless thyroiditis (silent thyroiditis). We report the case of a... | PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33892761 | 20,814,234 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A case of thyrotoxicosis-induced anemia in a patient with painless thyroiditis.
BACKGROUND
There have been several reports of secondary anemia associated with Graves' disease. There are no reports of secondary anemia resulting from thyrotoxicosis due to painless thyroiditis (silent thyroiditis). We report the case of a... | PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33892761 | 20,814,234 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | A case of thyrotoxicosis-induced anemia in a patient with painless thyroiditis.
BACKGROUND
There have been several reports of secondary anemia associated with Graves' disease. There are no reports of secondary anemia resulting from thyrotoxicosis due to painless thyroiditis (silent thyroiditis). We report the case of a... | PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33892761 | 20,814,234 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | A case of thyrotoxicosis-induced anemia in a patient with painless thyroiditis.
BACKGROUND
There have been several reports of secondary anemia associated with Graves' disease. There are no reports of secondary anemia resulting from thyrotoxicosis due to painless thyroiditis (silent thyroiditis). We report the case of a... | PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33892761 | 20,814,234 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperthyroidism'. | Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report.
BACKGROUND
Immune checkpoint inhibitors have recently become widely used for the management of advanced cancer patients. During the development of immune checkpoint inhibitors (ICPIs), it was quickly recogni... | AXITINIB, NIVOLUMAB, PAZOPANIB, PREDNISOLONE, SUNITINIB | DrugsGivenReaction | CC BY | 33892782 | 19,405,041 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report.
BACKGROUND
Immune checkpoint inhibitors have recently become widely used for the management of advanced cancer patients. During the development of immune checkpoint inhibitors (ICPIs), it was quickly recogni... | AXITINIB, NIVOLUMAB, PAZOPANIB, PREDNISOLONE, SUNITINIB | DrugsGivenReaction | CC BY | 33892782 | 19,405,041 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated hypophysitis'. | Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report.
BACKGROUND
Immune checkpoint inhibitors have recently become widely used for the management of advanced cancer patients. During the development of immune checkpoint inhibitors (ICPIs), it was quickly recogni... | AXITINIB, NIVOLUMAB, PAZOPANIB, PREDNISOLONE, SUNITINIB | DrugsGivenReaction | CC BY | 33892782 | 19,405,041 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Type 1 diabetes mellitus'. | Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report.
BACKGROUND
Immune checkpoint inhibitors have recently become widely used for the management of advanced cancer patients. During the development of immune checkpoint inhibitors (ICPIs), it was quickly recogni... | AXITINIB, NIVOLUMAB, PAZOPANIB, PREDNISOLONE, SUNITINIB | DrugsGivenReaction | CC BY | 33892782 | 19,405,041 | 2021-04-23 |
What is the weight of the patient? | Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report.
BACKGROUND
Immune checkpoint inhibitors have recently become widely used for the management of advanced cancer patients. During the development of immune checkpoint inhibitors (ICPIs), it was quickly recogni... | 56.3 kg. | Weight | CC BY | 33892782 | 19,442,442 | 2021-04-23 |
What was the dosage of drug 'HYDROCORTISONE'? | Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report.
BACKGROUND
Immune checkpoint inhibitors have recently become widely used for the management of advanced cancer patients. During the development of immune checkpoint inhibitors (ICPIs), it was quickly recogni... | 20 MG, DAILY | DrugDosageText | CC BY | 33892782 | 19,442,442 | 2021-04-23 |
What was the outcome of reaction 'Hyperglycaemia'? | Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report.
BACKGROUND
Immune checkpoint inhibitors have recently become widely used for the management of advanced cancer patients. During the development of immune checkpoint inhibitors (ICPIs), it was quickly recogni... | Recovered | ReactionOutcome | CC BY | 33892782 | 19,442,442 | 2021-04-23 |
What was the outcome of reaction 'Type 1 diabetes mellitus'? | Nivolumab-induced hypophysitis followed by acute-onset type 1 diabetes with renal cell carcinoma: a case report.
BACKGROUND
Immune checkpoint inhibitors have recently become widely used for the management of advanced cancer patients. During the development of immune checkpoint inhibitors (ICPIs), it was quickly recogni... | Recovering | ReactionOutcome | CC BY | 33892782 | 19,405,041 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19 pneumonia'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | ACETAMINOPHEN, AZITHROMYCIN, CEFTRIAXONE, HYDROXYCHLOROQUINE, LEVOTHYROXINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 33892788 | 19,418,538 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | ACETAMINOPHEN, AZITHROMYCIN, CEFTRIAXONE, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | ACETAMINOPHEN, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, HYDROXYCHLOROQUINE, LEVOTHYROXINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 33892788 | 19,443,398 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | AMPICILLIN, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, GENTAMICIN, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, MEROPENEM, OSELTAMIVIR PHOSPHATE, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33892788 | 19,713,792 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | ACETAMINOPHEN, AZITHROMYCIN, CEFTRIAXONE, HYDROXYCHLOROQUINE, LEVOTHYROXINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 33892788 | 19,418,538 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neonatal respiratory distress syndrome'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | ACETAMINOPHEN, AZITHROMYCIN, CEFTRIAXONE, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumomediastinum'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | ACETAMINOPHEN, AZITHROMYCIN, CEFTRIAXONE, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumothorax'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | ACETAMINOPHEN, AZITHROMYCIN, CEFTRIAXONE, HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | ACETAMINOPHEN, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, HYDROXYCHLOROQUINE, LEVOTHYROXINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 33892788 | 19,711,762 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | ACETAMINOPHEN, AZITHROMYCIN, CEFTRIAXONE, HYDROXYCHLOROQUINE, LEVOTHYROXINE, LOPINAVIR\RITONAVIR, OSELTAMIVIR PHOSPHATE | DrugsGivenReaction | CC BY | 33892788 | 19,418,538 | 2021-04-23 |
What was the administration route of drug 'AMPICILLIN'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33892788 | 19,713,792 | 2021-04-23 |
What was the administration route of drug 'GENTAMICIN'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33892788 | 19,713,792 | 2021-04-23 |
What was the dosage of drug 'AMPICILLIN'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | 50 MILLIGRAM/KILOGRAM, BID | DrugDosageText | CC BY | 33892788 | 19,713,792 | 2021-04-23 |
What was the dosage of drug 'GENTAMICIN'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | 4 MILLIGRAM/KILOGRAM, 1DOSE/48HOUR | DrugDosageText | CC BY | 33892788 | 19,713,792 | 2021-04-23 |
What was the dosage of drug 'MEROPENEM'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | 20 MILLIGRAM, BID | DrugDosageText | CC BY | 33892788 | 19,713,792 | 2021-04-23 |
What was the dosage of drug 'VANCOMYCIN HYDROCHLORIDE'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | 10 MILLIGRAM/KILOGRAM, EVERY 18 HOURS | DrugDosageText | CC BY | 33892788 | 19,713,792 | 2021-04-23 |
What was the outcome of reaction 'COVID-19 pneumonia'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Fatal | ReactionOutcome | CC BY | 33892788 | 19,418,538 | 2021-04-23 |
What was the outcome of reaction 'COVID-19'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Recovered | ReactionOutcome | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Fatal | ReactionOutcome | CC BY | 33892788 | 19,443,398 | 2021-04-23 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Recovered | ReactionOutcome | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Recovered | ReactionOutcome | CC BY | 33892788 | 19,418,538 | 2021-04-23 |
What was the outcome of reaction 'Neonatal respiratory distress syndrome'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Recovered | ReactionOutcome | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
What was the outcome of reaction 'Pneumomediastinum'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Recovered | ReactionOutcome | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
What was the outcome of reaction 'Pneumothorax'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Recovered | ReactionOutcome | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
What was the outcome of reaction 'Premature baby'? | Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.
BACKGROUND
Vertical transmission of coronavirus disease 2019 (COVID-19) from mother to newborn infant is doubtful, and very little is known about... | Recovered | ReactionOutcome | CC BY | 33892788 | 19,418,534 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease.
Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias... | AMANTADINE HYDROCHLORIDE, CARBIDOPA\LEVODOPA, CLOZAPINE, CYPROHEPTADINE, DONEPEZIL, PERGOLIDE, TRIHEXYPHENIDYL | DrugsGivenReaction | CC BY | 33893319 | 19,705,449 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease.
Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias... | AMANTADINE HYDROCHLORIDE, BACLOFEN, CARBIDOPA\LEVODOPA, DONEPEZIL, GABAPENTIN, LEVODOPA, PERGOLIDE, RILUZOLE, ROPINIROLE | DrugsGivenReaction | CC BY | 33893319 | 19,705,491 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease.
Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias... | AMANTADINE HYDROCHLORIDE, CARBIDOPA\LEVODOPA, CLOZAPINE, CYPROHEPTADINE, DONEPEZIL, PERGOLIDE, TRIHEXYPHENIDYL | DrugsGivenReaction | CC BY | 33893319 | 19,705,449 | 2021-04-23 |
What was the dosage of drug 'AMANTADINE HYDROCHLORIDE'? | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease.
Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias... | FOR THE NEXT YEAR | DrugDosageText | CC BY | 33893319 | 19,705,449 | 2021-04-23 |
What was the dosage of drug 'CLOZAPINE'? | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease.
Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias... | FOR THE NEXT YEAR | DrugDosageText | CC BY | 33893319 | 19,705,449 | 2021-04-23 |
What was the dosage of drug 'CYPROHEPTADINE'? | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease.
Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias... | FOR THE NEXT YEAR | DrugDosageText | CC BY | 33893319 | 19,705,449 | 2021-04-23 |
What was the dosage of drug 'DONEPEZIL'? | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease.
Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias... | FOR THE NEXT YEAR | DrugDosageText | CC BY | 33893319 | 19,705,449 | 2021-04-23 |
What was the dosage of drug 'ROPINIROLE'? | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease.
Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias... | VARIED FROM 0.625 MG DAILY TO 1.5 MG DAILY | DrugDosageText | CC BY | 33893319 | 19,705,491 | 2021-04-23 |
What was the dosage of drug 'TRIHEXYPHENIDYL'? | Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease.
Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias... | UNK UNK, QD,4?6 MG DAILY | DrugDosageText | CC BY | 33893319 | 19,705,449 | 2021-04-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C.
Justice-involved (JI) populations bear a disproportionate burden of HIV infection and are at risk of poor treatment outcomes. Drug resistance prevalence and emergence, and phylogenetic ... | ABACAVIR, DARUNAVIR\RITONAVIR, LAMIVUDINE | DrugsGivenReaction | CC BY | 33896212 | 20,456,032 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral mutation identified'. | HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C.
Justice-involved (JI) populations bear a disproportionate burden of HIV infection and are at risk of poor treatment outcomes. Drug resistance prevalence and emergence, and phylogenetic ... | ABACAVIR, DARUNAVIR\RITONAVIR, LAMIVUDINE | DrugsGivenReaction | CC BY | 33896212 | 20,456,032 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Virologic failure'. | HIV Drug Resistance and Transmission Networks Among a Justice-Involved Population at the Time of Community Reentry in Washington, D.C.
Justice-involved (JI) populations bear a disproportionate burden of HIV infection and are at risk of poor treatment outcomes. Drug resistance prevalence and emergence, and phylogenetic ... | ABACAVIR, DARUNAVIR\RITONAVIR, LAMIVUDINE | DrugsGivenReaction | CC BY | 33896212 | 20,456,032 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | AMPICILLIN SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | AMPICILLIN SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | AMPICILLIN SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
What was the administration route of drug 'AMPICILLIN SODIUM\SULBACTAM SODIUM'? | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33896869 | 19,420,003 | 2021-10-15 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
What was the outcome of reaction 'Atrial fibrillation'? | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | Fatal | ReactionOutcome | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
What was the outcome of reaction 'Cardiac failure'? | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | Fatal | ReactionOutcome | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
What was the outcome of reaction 'Hypotension'? | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | Fatal | ReactionOutcome | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
What was the outcome of reaction 'Posterior reversible encephalopathy syndrome'? | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | Fatal | ReactionOutcome | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
What was the outcome of reaction 'Thrombotic microangiopathy'? | Fatal Thrombotic Microangiopathy and Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis.
A 56-year-old woman presented with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody. No interstitial... | Fatal | ReactionOutcome | CC BY-NC-ND | 33896869 | 19,452,400 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholecystitis'. | Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant.
In patients with early-stage hepatocellular carcinoma, awaiting liver transplantation, current ... | DOXORUBICIN HYDROCHLORIDE, KETOROLAC TROMETHAMINE, METOCLOPRAMIDE, OMEPRAZOLE | DrugsGivenReaction | CC BY | 33897421 | 19,395,858 | 2021 |
What was the administration route of drug 'KETOROLAC TROMETHAMINE'? | Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant.
In patients with early-stage hepatocellular carcinoma, awaiting liver transplantation, current ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33897421 | 19,395,858 | 2021 |
What was the administration route of drug 'METOCLOPRAMIDE'? | Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant.
In patients with early-stage hepatocellular carcinoma, awaiting liver transplantation, current ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33897421 | 19,395,858 | 2021 |
What was the administration route of drug 'OMEPRAZOLE'? | Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant.
In patients with early-stage hepatocellular carcinoma, awaiting liver transplantation, current ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33897421 | 19,395,858 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Brain stem syndrome'. | Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without me... | ASPIRIN, CEFOTAXIME SODIUM, DEXAMETHASONE, ENOXAPARIN SODIUM, LEVOFLOXACIN, METHYLPREDNISOLONE, METRONIDAZOLE, REMDESIVIR, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33897582 | 20,061,269 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coma'. | Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without me... | ASPIRIN, CEFOTAXIME SODIUM, DEXAMETHASONE, ENOXAPARIN SODIUM, LEVOFLOXACIN, METHYLPREDNISOLONE, METRONIDAZOLE, REMDESIVIR, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33897582 | 20,061,269 | 2021 |
What was the administration route of drug 'CEFOTAXIME SODIUM'? | Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without me... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33897582 | 20,044,920 | 2021 |
What was the administration route of drug 'LEVOFLOXACIN'? | Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without me... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33897582 | 20,044,920 | 2021 |
What was the administration route of drug 'METRONIDAZOLE'? | Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without me... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33897582 | 20,044,920 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without me... | PULSE COURSE | DrugDosageText | CC BY | 33897582 | 20,044,920 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without me... | HIGH DOSE, PULSE COURSE | DrugDosageText | CC BY | 33897582 | 20,044,920 | 2021 |
What was the outcome of reaction 'Brain stem syndrome'? | Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without me... | Fatal | ReactionOutcome | CC BY | 33897582 | 20,061,269 | 2021 |
What was the outcome of reaction 'Coma'? | Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without me... | Fatal | ReactionOutcome | CC BY | 33897582 | 20,061,269 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.